8,100
Participants
Start Date
February 18, 2022
Primary Completion Date
May 25, 2029
Study Completion Date
May 25, 2029
9vHPV Vaccine
9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) L1 virus-like particle vaccine administered as a 0.5-mL IM injection
Placebo
Sterile saline solution administered as a 0.5 mL IM injection
Beijing Youan Hospital ( Site 0001), Beijing
The first affiliated hospital of China medical university ( Site 0041), Shenyang
Liaoning University of Traditional Chinese Medicine Affiliated Hospital ( Site 0048), Shenyang
Tianjin Second People's Hospital ( Site 0004), Tianjin
Zhejiang University School of Medicine - Affiliated Wenzhou Traditional Chinese Medicine Hospital (W, Wenzhou
The Second Affiliated Hospital Chongqing Medical University ( Site 0052), Chongqing
Chongqing Public Health Medical Center ( Site 0003), Chongqing
Hunan Provincial Center for Disease Control and Prevention ( Site 0040), Changsha
The Third Xiangya Hospital of Central South University ( Site 0033), Changsha
Loudi Disease Prevention and Control Center Zhiyebing Prevention And Treatment Hospital ( Site 0015), Louxing District
Qiyang Center for Disease Control and Prevention ( Site 0014), Yongzhou
Wuhan Union Hospital ( Site 0032), Wuhan
Southern Medical University Nanfang Hospital-Center for Drug Clinical Research ( Site 0031), Guangzhou
The University of Hong Kong - Shenzhen Hospital ( Site 0049), Shenzhen
Center for Disease Control and Prevention of Rong An ( Site 0046), Liuzhou
Mianyang Center for Disease Control and Prevention ( Site 0007), Mianyang
Santai County Center for Disease Control and Prevention ( Site 0008), Mianyang
Dazhu Disease Prevention and Control Center ( Site 0010), Dazhou
Yuechi Disease Prevention and Control Center ( Site 0009), Guang’an
Neijiang Center for Disease Control and Prevention ( Site 0011), Neijiang
First Affiliated Hospital of Kunming Medical University ( Site 0051), Kunming
Yunnan Provincial Infectious Disease Hospital ( Site 0042), Kunming
Binchuan County Center for Disease Control and Prevention ( Site 0022), Dali
Xiangyun County Center for Disease Control and Prevention ( Site 0021), Dali
The First Hospital of Lanzhou University ( Site 0034), Lanzhou
The Second Hospital of Nanjing (Tangshan Branch) ( Site 0028), Nanjing
Liucheng County Centers for Disease Control and Prevention ( Site 0045), Liuzhou
Xiangtan Disease Prevention and Control Center ( Site 0030), Xiangtan
Xiangxiang Disease Prevention and Control Center ( Site 0016), Xiangxiang
Tianjin People' s Hospital ( Site 0038), Tianjin
Yuanqu Center for Disease Control and Prevention ( Site 0019), Yuncheng
Yanhu Center for Disease Control and Prevention of Yuncheng ( Site 0018), Yuncheng
Yongji Center for Disease Control and Prevention ( Site 0026), Yuncheng
Ruicheng Center for Disease Control and Prevention ( Site 0025), Yuncheng
Merck Sharp & Dohme LLC
INDUSTRY